Press release
Global Rituximab Biosimilar Market Assessment –Clinical Trial/Pipeline Analysis, Brand/Originator Drug Historic Revenue and Forecast 2019- 2027 With keyplayer Analysis Like Amgen, AryoGen Pharmed, BioXpress Therapeutics, Boehringer Ingelheim, Celltrion,
Request for ToC/Proposal: https://bit.ly/2llXAAD
Rituximab is a chimeric anti-CD20 antibody that binds to the CD20 antigen present on the normal and malignant B cells surface. It is indicated for the treatment of blood cancer (CD20-positive) such as chronic lymphocytic leukemia and non-Hodgkin’s lymphoma as well as autoimmune disorder such as Rheumatoid arthritis.
Rituximab is marketed under the trade name of MabThera in Europe and rest of World, except Japan by Roche. In the United States it marketed as Rituxan by Genentech in partnership with Biogen Idec.In Japan it is marketed by Chugai and Zenyaku Kogyo Co. Ltd. It is approved in the U.S. in 1997 and by European Medical Agency in June 1998. Rituximab is one of the top selling pharmaceutical product of Roche Holding AG.Therefor many biosimilar pharmaceutical companies are focusingon product development of rituximab biosimilar to compel the biosimilar product market share.
The rituximab biosimilar market is expected to grow at higher pace during forecast period,since the rituximab is one of the best seller drug product that accounts for around 2.1 million prescriptions worldwide since the market launch. In addition, rituximab has lost its patent in the United States and Europe in 2016 and 2013 respectively.
The Rituximab biosimilar market is fragmented with presence of many players that operates in local as well as international market.
Global Rituximab biosimilar Market reports cover prominent players like Amgen, AryoGen Pharmed, BioXpress Therapeutics, Boehringer Ingelheim, Celltrion, Teva Pharmaceutical, Intas Biopharmaceuticals, JHL Biotech, mAbxience SA., Mylan, Pfizer, Sandoz, Zenotech Laboratories and many more.
Curious about this latest version of report?
Obtain Report Details @https://bit.ly/2llXAAD
Market Segments
• Global Rituximab biosimilar Market Outlook (Revenue, US$ Mn, 2017 - 2027) By Application
o Non-Hodgkin’s lymphoma,
o Chronic LymhocyticLeukemia,
o Rheumatoid arthritis and others
• Global Rituximab Biosimilar Market Outlook (Revenue, US$ Mn, 2017 - 2027) By Distribution Channel
o Hospital Pharmacy
o Online Pharmacy
o Retail Pharmacy
o Other Direct Distribution Channels
Why should buy this report:
To receive a comprehensive analysis of the prospects for global Rituximab biosimilar market
To receive industry overview and future trends Rituximab biosimilar market
To analyze the Rituximab biosimilar market drivers and challenges
To get information on Rituximab biosimilar market size and forecast
To get details on Rituximab biosimilar clinical trial/pipeline analysis
Originator drug historic revenue
Originator drug key news/industry activities
Major Mergers & Acquisition inRituximab biosimilar industry
For More Information @https://bit.ly/2llXAAD
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Rituximab Biosimilar Market Assessment –Clinical Trial/Pipeline Analysis, Brand/Originator Drug Historic Revenue and Forecast 2019- 2027 With keyplayer Analysis Like Amgen, AryoGen Pharmed, BioXpress Therapeutics, Boehringer Ingelheim, Celltrion, here
News-ID: 1876651 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.
Virtualized Evolved Packet Core Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Virtualized Evolved Packet Core Market- (By Offerings (Solutions(Virtualized Packet Gateway, Virtualized Mobility Management Entity (vMME), Policy and Charging Rules Function (PCRF)), Services (Consulting and Advisory Services, System Integration and Deployment Services, Maintenance and Support Services)), Deployment Mode (On-Premises, Cloud-based), By Network Type (LTE, 5G), By End-User (Telecommunication Service Providers, (Mobile Network Operators (MNOs), Virtual Network…
Medical Reference Apps Market to Record an Exponential CAGR by 2030
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Medical Reference Apps Market- by Type (Monthly and Annual Subscriptions), Application (Drug Information, Medical Conditions & Symptoms, Medical News & Development, Articles & Educational Reference Materials, and Other Applications), Types of Platform (Android and iOS), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1031
According to the latest research by InsightAce…
AI in Livestock Farming Market 2023 | Detailed Analysis Report to 2030
According to the latest research by InsightAce Analytic, the global Artificial Intelligence in Livestock Farming market is expected to register a CAGR of 26.2% during a forecast period of 2022-2030.
Download Free Report Brochure: https://www.insightaceanalytic.com/request-sample/1323
AI is just a reflection of human intelligence that employs algorithms to carry out a variety of chores that farmers previously did. Software, apps, and sensors powered by the Internet of Things are the main elements…
IoT for Fisheries and Aquaculture Market Exclusive Report to 2030
According to the latest research by InsightAce Analytic, the global IoT for Fisheries and Aquaculture market is valued at US$ 415.37 Million in 2021, and it is expected to reach US$ 1,232.32 Million by 2030, with a CAGR of 13.2% during a forecast period of 2022-2030.
Get Free Sample Copy of the Report :
https://www.insightaceanalytic.com/request-sample/1303
IoT has already demonstrated a wide range of application sectors in recent years. Internet of Things…
More Releases for Rituximab
Rituxan (rituximab) Drug Market Trends, Demand Service, Share, Industry Size, Gr …
LOS ANGELES, United States: QY Research offers an encyclopedic study of the global Rituxan (rituximab) Drug market with holistic insights into vital factors and aspects that impact future market growth. The global Rituxan (rituximab) Drug market has been analyzed for the forecast period 2022-2028 and historical period 2017-2021. In order to help players to gain comprehensive understanding of the global Rituxan (rituximab) Drug market and its critical dynamics, the research study…
2022 Rituximab Biosimilars Market Report, Overview, Size, Trends, Growth And For …
'Rituximab Biosimilars Global Market Report 2022 -Market Size, Trends, And Global Forecast 2022-2026' by The Business Research Company is the most comprehensive report available on this market, with analysis of the market's historic and forecast growth, drivers and restraints causing it, and highlights of the opportunities that companies in the industry can take on. The Rituximab Biosimilars market research report helps gain a truly global perspective of the Rituximab Biosimilars…
Global Rituximab Biosimilars Market 2021 : SWOT Analysis of Key Driving Factors …
Get up to 33% off on ALL market research reports at The Business Research Company's holiday sale; buy now!
https://www.thebusinessresearchcompany.com/global-market-reports
‘Rituximab Biosimilars Global Market Report 2021 – COVID-19 Growth And Change’ by The Business Research Company is the most comprehensive report available on this market, with analysis of the market’s historic and forecast growth, drivers and restraints causing this, and highlights of the opportunities that companies in the industry can take on.…
Complete Analysis On Rituximab Biosimilars Market | Global Key Trends Analysis, …
The Business Research Company offers "Rituximab Biosimilars Global Market Report 2021: COVID-19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It…
Rituximab Biosimilars Market Share, Growth Insights, Regional Overview, Competit …
The rituximab biosimilar market reached a value of nearly $1,602.1 million in 2020, having increased at a compound annual growth rate (CAGR) of 67.9% since 2015. The market is expected to grow from $1,602.1 million in 2020 to $3,474.2 million in 2025 at a rate of 16.7%. The market is then expected to grow at a CAGR of 10.5% from 2025 and reach $5,723.6 million in 2030.
The Business…
Rituximab Drug Market Primary Research, Secondary Research, Product Research, Si …
QY Research has published a latest and most trending report on Rituximab Drug Market offers detailed value chain assessment, comprehensive study on market dynamics including drivers, restraints and opportunities, recent trends, and industry performance analysis. Furthermore, it digs deep into critical aspects of key subjects such as market competition, regional growth, and market segmentation so that readers could gain a sound understanding of the global Rituximab Drug market.
The global Rituximab…
